RxDoctor Payments Data

Christopher Lynch, MD

Adult Reconstructive Orthopaedic Surgery · Branford, CTNPI 1952307456

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $40,657 of the $48,246 with a category attached, or 84.3%. 20 manufacturers reported payments, led by B. Braun Medical Inc. at 46.7% of the total. Reporting peaked in 2019 at $22,184 and has fallen 98.2% since, to $390 in 2025.

$48,246in general payments, 2019–2025

Across 155 payments — averaging $311.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • B. Braun Medical Inc.$23K
  • Orthalign Inc$17K
  • Medacta USA, Inc.$2K
  • Depuy Synthes Products, Inc.$2K
  • Smith+Nephew$2K
  • Johnson & Johnson$637
  • plus $2K from 14 others

What the payments were for

  • Consulting fees$40,65784%
  • Speaking & faculty fees$1,6003%
  • Travel & lodging$2,6195%
  • Food & beverage$3,3707%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few adult reconstructive orthopaedic surgery providers in Connecticutto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$275,159
Medicare patients
464
Services billed
2,918

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium82$6,485
Amoxicillin-Clavulanate Pot ErAmoxicillin/Potassium Clav22$877
Celecoxib32$715
Methylprednisolone83$496
Amoxicillin180$334
Clindamycin Hcl64$212
Meloxicam25$69

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Branford

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →